315 related articles for article (PubMed ID: 2253037)
1. Ganglioside AGF2 promotes task-specific recovery and attenuates the cholinergic hypofunction induced by AF64A.
Emerich DF; Walsh TJ
Brain Res; 1990 Sep; 527(2):299-307. PubMed ID: 2253037
[TBL] [Abstract][Full Text] [Related]
2. Ganglioside AGF2 prevents the cognitive impairments and cholinergic cell loss following intraventricular colchicine.
Emerich DF; Walsh TJ
Exp Neurol; 1991 Jun; 112(3):328-37. PubMed ID: 2029933
[TBL] [Abstract][Full Text] [Related]
3. Transplantation of fetal cholinergic neurons into the hippocampus attenuates the cognitive and neurochemical deficits induced by AF64A.
Emerich DF; Black BA; Kesslak JP; Cotman CW; Walsh TJ
Brain Res Bull; 1992 Feb; 28(2):219-26. PubMed ID: 1596741
[TBL] [Abstract][Full Text] [Related]
4. Long-term exposure to high levels of corticosterone aggravates AF64A-induced cholinergic hypofunction in rat hippocampus in vivo.
Amoroso D; Kindel G; Wülfert E; Hanin I
Brain Res; 1994 Oct; 661(1-2):9-18. PubMed ID: 7530584
[TBL] [Abstract][Full Text] [Related]
5. AF64A-induced working memory impairment: behavioral, neurochemical and histological correlates.
Chrobak JJ; Hanin I; Schmechel DE; Walsh TJ
Brain Res; 1988 Oct; 463(1):107-17. PubMed ID: 3196899
[TBL] [Abstract][Full Text] [Related]
6. AF64A (ethylcholine aziridinium ion), a cholinergic neurotoxin, selectively impairs working memory in a multiple component T-maze task.
Chrobak JJ; Hanin I; Walsh TJ
Brain Res; 1987 Jun; 414(1):15-21. PubMed ID: 3620916
[TBL] [Abstract][Full Text] [Related]
7. Reversible cholinergic changes induced by AF64A in rat hippocampus and possible septal compensatory effect.
el Tamer A; Corey J; Wülfert E; Hanin I
Neuropharmacology; 1992 Apr; 31(4):397-402. PubMed ID: 1522957
[TBL] [Abstract][Full Text] [Related]
8. Induction of cortical cholinergic hypofunction and memory retention deficits through intracortical AF64A infusions.
Mouton PR; Meyer EM; Dunn AJ; Millard W; Arendash GW
Brain Res; 1988 Mar; 444(1):104-18. PubMed ID: 3359282
[TBL] [Abstract][Full Text] [Related]
9. Dose- and delay-dependent working/episodic memory impairments following intraventricular administration of ethylcholine aziridinium ion (AF64A).
Chrobak JJ; Walsh TJ
Behav Neural Biol; 1991 Sep; 56(2):200-12. PubMed ID: 1759941
[TBL] [Abstract][Full Text] [Related]
10. Impairment of spatial working memory of rats in radial maze performance induced by ethylcholine mustard aziridinium picrylsulfonate (AF64A-P): retention curve analysis.
Inagawa K
Nihon Shinkei Seishin Yakurigaku Zasshi; 1994 Feb; 14(1):9-17. PubMed ID: 8048282
[TBL] [Abstract][Full Text] [Related]
11. Beneficial effects of FKS-508 (AF102B), a selective M1 agonist, on the impaired working memory in AF64A-treated rats.
Nakahara N; Iga Y; Saito Y; Mizobe F; Kawanishi G
Jpn J Pharmacol; 1989 Dec; 51(4):539-47. PubMed ID: 2615046
[TBL] [Abstract][Full Text] [Related]
12. Hemicholinium-3 prevents the working memory impairments and the cholinergic hypofunction induced by ethylcholine aziridinium ion (AF64A).
Chrobak JJ; Spates MJ; Stackman RW; Walsh TJ
Brain Res; 1989 Dec; 504(2):269-75. PubMed ID: 2598029
[TBL] [Abstract][Full Text] [Related]
13. Vitamin E prevents the place learning deficit and the cholinergic hypofunction induced by AF64A.
Wörtwein G; Stackman RW; Walsh TJ
Exp Neurol; 1994 Jan; 125(1):15-21. PubMed ID: 8307121
[TBL] [Abstract][Full Text] [Related]
14. Effects of AF64A on gene expression of choline acetyltransferase (ChAT) in the septo-hippocampal pathway and striatum in vivo.
Fan QI; Hanin I
Neurochem Res; 1999 Jan; 24(1):15-24. PubMed ID: 9973232
[TBL] [Abstract][Full Text] [Related]
15. Behavioral and neuroanatomical consequences of a unilateral intraventricular infusion of AF64A and limitations on the neuroprotective effects of nimodipine.
Maier DL; Isaacson RL
Brain Res; 1994 Jun; 648(2):281-90. PubMed ID: 7922542
[TBL] [Abstract][Full Text] [Related]
16. Distinct profile of working memory errors following acute or chronic disruption of the cholinergic septohippocampal pathway.
Stackman RW; Walsh TJ
Neurobiol Learn Mem; 1995 Nov; 64(3):226-36. PubMed ID: 8564376
[TBL] [Abstract][Full Text] [Related]
17. Brain-derived neurotrophic factor induced stimulation of septal choline acetyltransferase activity in ethylcholine mustard aziridinium treated rats.
Willson CA; Hanin I
Neurosci Lett; 1997 Jul; 229(3):149-52. PubMed ID: 9237480
[TBL] [Abstract][Full Text] [Related]
18. AF64A (ethylcholine mustard aziridinium) impairs acquisition and performance of a spatial, but not a cued water maze task: relation to cholinergic hypofunction.
Opello KD; Stackman RW; Ackerman S; Walsh TJ
Physiol Behav; 1993 Dec; 54(6):1227-33. PubMed ID: 7507594
[TBL] [Abstract][Full Text] [Related]
19. AF64A, a cholinergic neurotoxin, selectively depletes acetylcholine in hippocampus and cortex, and produces long-term passive avoidance and radial-arm maze deficits in the rat.
Walsh TJ; Tilson HA; DeHaven DL; Mailman RB; Fisher A; Hanin I
Brain Res; 1984 Oct; 321(1):91-102. PubMed ID: 6548653
[TBL] [Abstract][Full Text] [Related]
20. Role of glucocorticoids in the cholinergic degeneration in rat hippocampus induced by ethylcholine aziridinium (AF64A).
Hörtnagl H; Berger ML; Havelec L; Hornykiewicz O
J Neurosci; 1993 Jul; 13(7):2939-45. PubMed ID: 7687281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
